Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
27 This is reassuring given that side effects (most commonly gastrointestinal [eg nausea, constipation]) with oral therapy are dose related
Scott H
FDA scientists remain unconvinced of peptide safety and benefits In recent years, the FDA has warned Americans about the risks of injecting peptides like BPC-157 and TB-500, another compound set for review Thursday
The peptide can be administered subcutaneously, with some researchers using it in the same protocol alongside BPC-157 and TB-500
However, side effects such as temporary swelling, allergic reaction, and interactions with other medications are possible
Delatour T, Mally A, Richoz J et al (2008) Absence of 2-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS
